Authors:
Espersen, C
Pakkenberg, B
Harder, E
Pallesen, G
Gerstoft, J
Pedersen, BK
Ullum, H
Citation: C. Espersen et al., High levels of CD8-positive lymphocytes expressing CD45R0, granzyme B, andKappa i-67 in lymph nodes of HIV-infected individuals are not associated with increased mortality, AIDS RES H, 17(4), 2001, pp. 287-293
Authors:
Aladdin, H
Von Essen, M
Schjerling, P
Katzenstein, T
Gerstoft, J
Skinhoj, P
Pedersen, BK
Ullum, H
Citation: H. Aladdin et al., T-cell mean telomere lengths changes in treatment naive HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART, SC J IMMUN, 54(3), 2001, pp. 301-305
Authors:
Aladdin, H
Larsen, CS
Schjerling, P
Moller, BK
Buhl, MR
Gerstoft, J
Pedersen, BK
Ullum, H
Citation: H. Aladdin et al., Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patients, SC J IMMUN, 53(3), 2001, pp. 315-319
Authors:
Sondergaard, SR
Ostrowski, K
Ullum, H
Pedersen, BK
Citation: Sr. Sondergaard et al., Changes in plasma concentrations of interleukin-6 and interleukin-1 receptor antagonists in response to adrenaline infusion in humans, EUR J A PHY, 83(1), 2000, pp. 95-98
Citation: Sr. Sondergaard et al., Proliferative and cytotoxic capabilities of CD16+CD56- and CD16 +/- CD56+ natural killer cells, APMIS, 108(12), 2000, pp. 831-837
Authors:
Nielsen, SD
Sorensen, TU
Aladdin, H
Ersboll, AK
Mathiesen, L
Ullum, H
Gerstoft, J
Nielsen, JO
Pedersen, BK
Nielsen, SD
Citation: Sd. Nielsen et al., The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals, SC J IMMUN, 52(3), 2000, pp. 298-303
Authors:
Aladdin, H
Ullum, H
Schjerling, P
Jensen, MS
Nielsen, SD
Mathiesen, L
Gerstoft, J
Skinhoj, P
Pedersen, BK
Citation: H. Aladdin et al., Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: Results from a randomized, placebo-controlled trial, SC J IMMUN, 52(2), 2000, pp. 212-216
Authors:
Aladdin, H
Ullum, H
Katzenstein, T
Gerstoft, J
Skinhoj, P
Pedersen, BK
Citation: H. Aladdin et al., Immunological and virological changes in antiretroviral naive human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART, SC J IMMUN, 51(5), 2000, pp. 520-525
Authors:
Aladdin, H
Larsen, CS
Moller, BK
Ullum, H
Buhl, MR
Gerstoft, J
Skinhoj, P
Pedersen, BK
Citation: H. Aladdin et al., Effects of subcutaneous interleukin-2 therapy on phenotype and function ofperipheral blood mononuclear cells in human immunodeficiency virus infected patients, SC J IMMUN, 51(2), 2000, pp. 168-175
Authors:
Ullum, H
Lepri, AC
Katzenstein, TL
Phillips, AN
Skinhoj, P
Gerstoft, J
Pedersen, BK
Citation: H. Ullum et al., Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin a in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels, SC J IN DIS, 32(4), 2000, pp. 371-376
Authors:
Christensen, JK
Eugen-Olsen, J
Sorensen, M
Ullum, H
Gjedde, SB
Pedersen, BK
Nielsen, JO
Krogsgaard, K
Citation: Jk. Christensen et al., Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus, J INFEC DIS, 181(5), 2000, pp. 1796-1799
Authors:
Aladdin, H
Ullum, H
Nielsen, SD
Espersen, C
Mathiesen, L
Katzenstein, TL
Gerstoft, J
Skinhoj, P
Pedersen, BK
Citation: H. Aladdin et al., Granulocyte colony-stimulating factor increases CD4(+) T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: Results from a randomized, placebo-controlled trial, J INFEC DIS, 181(3), 2000, pp. 1148-1152
Authors:
Sidenius, N
Sier, CFM
Ullum, H
Pedersen, BK
Lepri, AC
Blasi, F
Eugen-Olsen, J
Citation: N. Sidenius et al., Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection, BLOOD, 96(13), 2000, pp. 4091-4095
Authors:
Sondergaard, SR
Aladdin, H
Ullum, H
Gerstoft, J
Skinhoj, P
Pedersen, BK
Citation: Sr. Sondergaard et al., Immune function and phenotype before and after highly active antiretroviral therapy, J ACQ IMM D, 21(5), 1999, pp. 376-383
Authors:
Aladdin, H
Ullum, H
Lepri, AC
Leffers, H
Katzenstein, T
Gerstoft, J
Gjedde, SB
Phillips, AN
Skinhoj, P
Pedersen, BK
Citation: H. Aladdin et al., Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death, SC J IMMUN, 50(2), 1999, pp. 223-227
Authors:
Ullum, H
Katzenstein, T
Aladdin, H
Nielsen, C
Sondergaard, SR
Gerstoft, J
Skinhoj, P
Pedersen, BK
Citation: H. Ullum et al., Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatment, SC J IMMUN, 49(5), 1999, pp. 539-547
Authors:
Sondergaard, SR
Ullum, H
Skinhoj, P
Pedersen, BK
Citation: Sr. Sondergaard et al., Epinephrine-induced mobilization of natural killer (NK) cells and NK-like T cells in HIV-infected patients, CELL IMMUN, 197(2), 1999, pp. 91-98